Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 20 of 166

    1.

    Balancing safety of dietary supplements with the free market.

    Lewis JD, Strom BL.

    Ann Intern Med. 2002 Apr 16;136(8):616-8. No abstract available. PMID: 11955030 [PubMed - indexed for MEDLINE]Related articlesFree article

    2.

    Summary for patients. Liver failure associated with the dietary supplement LipoKinetix.

    [No authors listed]

    Ann Intern Med. 2002 Apr 16;136(8):I42. No abstract available. PMID: 11955047 [PubMed - indexed for MEDLINE]Related articlesFree article

    3.

    'Dietary supplement' warning.

    [No authors listed]

    FDA Consum. 2002 Mar-Apr;36(2):4. No abstract available. PMID: 11989472 [PubMed - indexed for MEDLINE]Related articlesFree article

    4.

    Severe hepatotoxicity associated with the dietary supplement LipoKinetix.

    Favreau JT, Ryu ML, Braunstein G, Orshansky G, Park SS, Coody GL, Love LA, Fong TL.

    Ann Intern Med. 2002 Apr 16;136(8):590-5.PMID: 11955027 [PubMed - indexed for MEDLINE]Related articlesFree article

    5.

    The FDA, regulation, and the risk of stroke.

    Fleming GA.

    N Engl J Med. 2000 Dec 21;343(25):1886-7. No abstract available. PMID: 11117982 [PubMed - indexed for MEDLINE]Related articles

    6.

    High prevalence of potentially hepatotoxic herbal supplement use in patients with fulminant hepatic failure.

    Estes JD, Stolpman D, Olyaei A, Corless CL, Ham JM, Schwartz JM, Orloff SL.

    Arch Surg. 2003 Aug;138(8):852-8.PMID: 12912743 [PubMed - indexed for MEDLINE]Related articlesFree article

    7.

    Inappropriate advertising of dietary supplements.

    Applequist WL.

    N Engl J Med. 2003 May 29;348(22):2255-6; author reply 2255-6. No abstract available. PMID: 12774809 [PubMed - indexed for MEDLINE]Related articles

    8.

    Inappropriate advertising of dietary supplements.

    de Lemos ML.

    N Engl J Med. 2003 May 29;348(22):2255-6; author reply 2255-6. No abstract available. PMID: 12774807 [PubMed - indexed for MEDLINE]Related articles

    9.

    Ephedra-free is not danger-free.

    Marcus DM, Grollman AP.

    Science. 2003 Sep 19;301(5640):1669-71; author reply 1669-71. No abstract available. PMID: 14500960 [PubMed - indexed for MEDLINE]Related articles

    10.

    Ephedra: yesterday, DSHEA, and tomorrow--a ten year perspective on the Dietary Supplement Health and Education Act of 1994.

    Seamon MJ, Clauson KA.

    J Herb Pharmacother. 2005;5(3):67-86. Review.PMID: 16520299 [PubMed - indexed for MEDLINE]Related articles

    11.

    Alternative medicine--the risks of untested and unregulated remedies.

    Angell M, Kassirer JP.

    N Engl J Med. 1998 Sep 17;339(12):839-41. No abstract available. PMID: 9738094 [PubMed - indexed for MEDLINE]Related articles

    12.

    Facing crackdown, dietary supplement companies promise changes.

    Nolen RS.

    J Am Vet Med Assoc. 2002 Aug 15;221(4):479-81, 483. No abstract available. PMID: 12184694 [PubMed - indexed for MEDLINE]Related articles

    13.

    The need for regulation of dietary supplements--lessons from ephedra.

    Fontanarosa PB, Rennie D, DeAngelis CD.

    JAMA. 2003 Mar 26;289(12):1568-70. Epub 2003 Mar 10. No abstract available. PMID: 12672775 [PubMed - indexed for MEDLINE]Related articles

    14.

    Workshop overview: Hepatotoxicity assessment for botanical dietary supplements.

    Willett KL, Roth RA, Walker L.

    Toxicol Sci. 2004 May;79(1):4-9. Epub 2004 Feb 19. Review.PMID: 14976355 [PubMed - indexed for MEDLINE]Related articlesFree article

    15.

    Drug safety. IOM recommends action on dietary supplements.

    Stokstad E.

    Science. 2004 Apr 9;304(5668):188. No abstract available. PMID: 15073343 [PubMed - indexed for MEDLINE]Related articles

    16.

    Essays in public health and preventive medicine. A call to Pharms: the need for tighter FDA regulation of the neutraceutical industry.

    Dobrin J.

    Mt Sinai J Med. 2006 Mar;73(2):565-6. No abstract available. PMID: 16685816 [PubMed - indexed for MEDLINE]Related articlesFree article

    17.

    FDA perspectives on supplement use by patients on antithrombotic therapy: dietary supplement regulatory overview.

    Woo JJ.

    Thromb Res. 2005;117(1-2):193-6; discussion 201-7. Epub 2005 Oct 25. No abstract available. PMID: 16253311 [PubMed - indexed for MEDLINE]Related articles

    18.

    What makes consumers think dietary supplements are safe and effective? The role of disclaimers and FDA approval.

    Dodge T, Kaufman A.

    Health Psychol. 2007 Jul;26(4):513-7.PMID: 17605572 [PubMed - indexed for MEDLINE]Related articles

    19.

    FDA perspectives on supplement use by patients on antithrombotic therapy.

    Kim MJ.

    Thromb Res. 2005;117(1-2):197-200; discussion 201-7. Epub 2005 Sep 26. No abstract available. PMID: 16188297 [PubMed - indexed for MEDLINE]Related articles

    20.

    The Dietary Supplement and Health Education Act and supplements: dietary and nutritional supplements need no more regulations.

    Wollschlaeger B.

    Int J Toxicol. 2003 Sep-Oct;22(5):387-90.PMID: 14555412 [PubMed - indexed for MEDLINE]Related articles

    Display Settings:

    Format
    Items per page
    Sort by

    Send to:

    Choose Destination

    Supplemental Content

    Find related data